Cargando…
Intravenous Amoxicillin Plus Intravenous Gentamicin for Children with Severe Pneumonia in Bangladesh: An Open-Label, Randomized, Non-Inferiority Controlled Trial
The World Health Organization (WHO) recommends intravenous (IV) ampicillin and gentamicin as first-line therapy to treat severe pneumonia in children under five years of age. Ampicillin needs to be administered at a six-hourly interval, which requires frequent nursing intervention and bed occupancy...
Autores principales: | Shahrin, Lubaba, Chisti, Mohammod Jobayer, Sarmin, Monira, Rahman, Abu Sayem Mirza Md. Hasibur, Shahid, Abu Sadat Mohammad Sayeem Bin, Islam, Md. Zahidul, Afroze, Farzana, Huq, Sayeeda, Ahmed, Tahmeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707665/ https://www.ncbi.nlm.nih.gov/pubmed/34947830 http://dx.doi.org/10.3390/life11121299 |
Ejemplares similares
-
Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial
por: Shahrin, Lubaba, et al.
Publicado: (2020) -
Risk factors and outcome of Shigella encephalopathy in Bangladeshi children
por: Afroze, Farzana, et al.
Publicado: (2017) -
Factors associated with severe sepsis in diarrheal adults and their outcome at an urban hospital, Bangladesh: A retrospective analysis
por: Sarmin, Monira, et al.
Publicado: (2021) -
Bacteremia in Diarrheal Children With Severe
Pneumonia
por: Saha, Haimanti, et al.
Publicado: (2019) -
Risk Factors for Death in Bangladeshi Children Under 5 Years of Age Hospitalized for Diarrhea and Severe Respiratory Distress in an Urban Critical Care Ward
por: Alam, Tahmina, et al.
Publicado: (2017)